| Business Summary | | Biosite,
Inc.,
formerly
known
as
Biosite
Diagnostics,
Inc.,
is
a
research-based
diagnostics
company
dedicated
to
the
discovery
and
development
of
novel
protein-based
tests
that
improve
a
physician's
ability
to
diagnose
disease.
The
Company
combines
separate,
yet
integrated
discovery
and
diagnostics
businesses
to
access
proteomics
research,
identify
proteins
with
high
diagnostic
utility,
develop
and
commercialize
products
and
educate
the
medical
community
on
new
approaches
to
diagnosis.
The
Company's
diagnostics
business
is
a
provider
of
rapid
tests
that
aid
in
the
diagnosis
of
a
variety
of
critical
diseases.
These
tests
are
sold
worldwide
primarily
for
use
in
emergency
departments
and
hospital
laboratories.
Biosite's
two
product
platforms
are
designed
to
provide
rapid
results
through
either
qualitative
visual
readings
or
quantitative
meter
readings. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Biosite,
Inc.
develops,
manufactures
and
markets
diagnostic
products
that
improve
the
quality
of
patient
care
and
simplify
the
practice
of
laboratory
medicine.
For
the
six
months
ended
6/30/01,
revenues
rose
19%
to
$31.4
million.
Net
income
rose
29%
to
$3.4
million.
Revenues
reflect
growth
in
net
sales
of
the
company's
Triage
Cardiac
System
and
sales
related
to
the
licensing
of
technology.
Earnings
also
reflect
increased
gross
profit
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Timothy Wollaeger, 57 Chairman | -- | -- | Kim Blickenstaff, 48 Pres,
CEO, Treasurer, Sec., | $517K | $3.7M | Thomas Watlington, 45 Sr.
VP - Commercial Operations | 343K | 61K | Christopher Twomey, 41 VP
of Fin. and CFO | 310K | 870K | Peter Witerzens, Ph.D., 59 VP,
Operations | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|